Crispr Therapeutics shares owned by EFG Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by EFG Asset Management
from 13F filings
Historical chart of EFG Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by EFG Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.6M | 74k | 62.60 |
| 2023-09-30 | $3.8M | 83k | 45.41 |
| 2023-06-30 | $4.2M | 75k | 56.15 |
| 2023-03-31 | $4.3M | 95k | 45.25 |
| 2022-12-31 | $3.8M | 94k | 40.33 |
| 2022-09-30 | $5.5M | 84k | 65.39 |
| 2022-06-30 | $4.9M | 80k | 60.80 |
| 2022-03-31 | $4.8M | 76k | 62.81 |